Position in NVS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,926,872
+$48,811 QoQ
Shares Held
12,295
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#441
of 1,603 holders
Holding Since
Mar 2020
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Henshaw Capital LLC holds $143,586,258 across 3 Drug Manufacturers - General names. NVS ranks #2 (1.3% of the industry book) .
All Filings in NVS
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,926,872 | 12,295 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $1,878,061 | 12,295 | Shares | Sole | 2026-05-28 | |
| 2025-12-31 | $670,737 | 4,865 | Shares | Sole | 2026-05-28 | |
| 2025-06-30 | $813,671 | 6,724 | Shares | Sole | 2026-05-28 | |
| 2025-03-31 | $749,591 | 6,724 | Shares | Sole | 2026-05-28 | |
| 2024-12-31 | $733,328 | 7,536 | Shares | Sole | 2026-05-28 | |
| 2024-09-30 | $948,109 | 8,243 | Shares | Sole | 2026-05-28 | |
| 2024-06-30 | $210,152 | 1,974 | Shares | Sole | 2026-05-28 | |
| 2020-09-30 | $307,577 | 3,537 | Shares | Sole | 2026-05-28 | |
| 2020-06-30 | $308,921 | 3,537 | Shares | Sole | 2026-05-28 | |
| 2020-03-31 | $291,625 | 3,537 | Shares | Sole | 2026-05-28 | |
| No filing history on record for this holder in this stock. | ||||||